HHT

Questions discussed in this category

How do you decide between systemic antiangiogenic therapies for HHT?

When would you consider pomalidomide over bevacizumab?

1 Answer available

Do you consider the use of bevacizumab in patients with HHT who have high output cardiac failure related to liver AVMs who also have cerebral AVMs?

1 Answer available

Papers discussed in this category

JAMA,

Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.

Ann Intern Med, 2020 Sep 08

Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.

Related Topics